Skip to main content
Clinical Trials/NCT06163768
NCT06163768RecruitingNot Applicable

Effects of Insulin Resistance in Non-diabetic Acute Coronary Syndrome Patients by the Homeostasis Model Assessment Index (HOMA2-IR)

University of Medicine and Pharmacy at Ho Chi Minh City1 site in 1 country1 target enrollmentStarted: December 31, 2023Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Recruiting
Sponsor
Enrollment
1
Locations
1
Primary Endpoint
Model HOMA-IR

Study Overview

Brief Summary

Effects of insulin resistance in non-diabetic acute coronary syndrome patients by the homeostasis model assessment index (HOMA2-IR)

Detailed Description

Help patients know about insulin resistance. If this condition persists for a long time, it will reduce the ability to produce insulin, thereby leading to increased blood sugar levels, causing type 2 diabetes. Helping doctors have a more general view, in order to come up with a strategy more effective monitoring and treatment, preventing diabetes and cardiovascular events.

Study Design

Study Type
Interventional
Allocation
Na
Intervention Model
Single Group
Primary Purpose
Prevention
Masking
None

Eligibility Criteria

Ages
18 Years to 60 Years (Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • •Control group The researcher collected samples from healthy people over 18 years old who came for a health check and were concluded to have good health at the Health Examination Department of University of Medicine and Pharmacy Hospital, Ho Chi Minh City. Not falling within the

Exclusion Criteria

  • •and agreeing to participate in the study were included in the study.
  • •Researchers -All patients diagnosed with Acute coronary syndrome who were over 18 years old, met the inclusion criteria and did not have exclusion criteria, and agreed to participate in the study were included in the study.
  • •Exclusion Criteria:
  • •Control group
  • •Patients < 18 years old.
  • •History of heart disease or stroke
  • •Exclude diabetic subjects
  • •Exclude subjects at high risk of insulin resistance
  • •Researchers
  • •Have diabetes or have previously been diagnosed with diabetes.
  • •Patients < 18 years old.
  • •The patient does not participate in follow-up examinations and does not follow up treatment at the medical facility.
  • •The patient died before reaching the hospital.
  • •Patients with severe medical diseases: cirrhosis, cancer, obstructive pulmonary disease chronic obstructive pulmonary disease, chronic heart failure, severe kidney failure.

Arms & Interventions

insulin

Other

This is a prospective study, without intervention in the clinical treatment plan at the hospital

Intervention: Insulin resistance (Procedure)

Outcomes

Primary Outcomes

Model HOMA-IR

Time Frame: January 2026

Use SPSS software to analyze data

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
University of Medicine and Pharmacy at Ho Chi Minh City
Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Nguyen Ngoc Minh Thu

University of Medicine and Pharmacy at Ho Chi Minh City

University of Medicine and Pharmacy at Ho Chi Minh City

Study Sites (1)

Loading locations...

Similar Trials